Last updated on September 2016

A clinical research study to evaluate the added benefit of an investigational drug in people with moderate Alzheimer’s disease who are currently taking stable doses of Donepezil and either Memantine or Namenda XR.


Brief description of study

A clinical research study to evaluate the added benefit of an investigational drug in people with moderate Alzheimer’s disease who are currently taking stable doses of Donepezil and either Memantine or Namenda XR.

Detailed Study Description

SPRI Clinical Trials of Brooklyn, under the sponsorship of Suven Life Sciences, is currently participating in the clinical evaluation of the safety and effectiveness of an investigational drug in persons with moderate dementia due to Alzheimer’s disease.

Clinical Study Identifier: TX145342

Find a site near you

Start Over

SPRI Clinical Trials Brooklyn

3044 Coney Island Avenue Suite 201 Brooklyn, NY USA
  Connect »